Earnings Troubles May Signal Larger Issues for Maider Medical Industry Equipment (SHSE:688310) Shareholders
Earnings Troubles May Signal Larger Issues for Maider Medical Industry Equipment (SHSE:688310) Shareholders
Despite Maider Medical Industry Equipment Co. Ltd.'s (SHSE:688310) recent earnings report having lackluster headline numbers, the market responded positively. Sometimes, shareholders are willing to ignore soft numbers with the hope that they will improve, but our analysis suggests this is unlikely for Maider Medical Industry Equipment.
儘管邁德醫療工業設備有限公司有限公司。's(SHSE: 688310)最近的業績顯示標題數據乏善可陳,市場反應積極。有時,股東願意忽視軟數字,希望這些數字能有所改善,但我們的分析表明,對於Maider Medical Industry Equipment而言,這不太可能。
How Do Unusual Items Influence Profit?
不尋常的物品如何影響利潤?
Importantly, our data indicates that Maider Medical Industry Equipment's profit received a boost of CN¥13m in unusual items, over the last year. While we like to see profit increases, we tend to be a little more cautious when unusual items have made a big contribution. We ran the numbers on most publicly listed companies worldwide, and it's very common for unusual items to be once-off in nature. Which is hardly surprising, given the name. If Maider Medical Industry Equipment doesn't see that contribution repeat, then all else being equal we'd expect its profit to drop over the current year.
重要的是,我們的數據表明,與去年相比,邁德醫療工業設備的利潤在不尋常物品方面增加了1300萬元人民幣。雖然我們希望看到利潤增加,但當不尋常的物品做出重大貢獻時,我們往往會更加謹慎一些。我們統計了全球大多數上市公司的數字,不尋常的物品在自然界中很常見。考慮到這個名字,這並不奇怪。如果Maider Medical Industry Equipment認爲這一捐款不會重演,那麼在其他條件相同的情況下,我們預計其本年度的利潤將下降。
That might leave you wondering what analysts are forecasting in terms of future profitability. Luckily, you can click here to see an interactive graph depicting future profitability, based on their estimates.
這可能會讓你想知道分析師對未來盈利能力的預測。幸運的是,您可以單擊此處查看根據他們的估計描繪未來盈利能力的交互式圖表。
Our Take On Maider Medical Industry Equipment's Profit Performance
我們對邁德醫療行業設備的利潤表現的看法
Arguably, Maider Medical Industry Equipment's statutory earnings have been distorted by unusual items boosting profit. Because of this, we think that it may be that Maider Medical Industry Equipment's statutory profits are better than its underlying earnings power. Nonetheless, it's still worth noting that its earnings per share have grown at 48% over the last three years. Of course, we've only just scratched the surface when it comes to analysing its earnings; one could also consider margins, forecast growth, and return on investment, among other factors. In light of this, if you'd like to do more analysis on the company, it's vital to be informed of the risks involved. To that end, you should learn about the 2 warning signs we've spotted with Maider Medical Industry Equipment (including 1 which is significant).
可以說,提高利潤的不尋常項目扭曲了邁德醫療工業設備的法定收益。因此,我們認爲邁德醫療工業設備的法定利潤可能好於其基礎盈利能力。儘管如此,仍然值得注意的是,其每股收益在過去三年中增長了48%。當然,我們只是在分析其收益時才浮出水面;人們還可以考慮利潤率、預測增長和投資回報率等因素。有鑑於此,如果你想對公司進行更多分析,了解所涉及的風險至關重要。爲此,你應該了解我們在Maider醫療行業設備上發現的2個警告信號(包括一個重要的警告信號)。
This note has only looked at a single factor that sheds light on the nature of Maider Medical Industry Equipment's profit. But there is always more to discover if you are capable of focussing your mind on minutiae. For example, many people consider a high return on equity as an indication of favorable business economics, while others like to 'follow the money' and search out stocks that insiders are buying. While it might take a little research on your behalf, you may find this free collection of companies boasting high return on equity, or this list of stocks with significant insider holdings to be useful.
本報告僅研究了揭示邁德醫療工業設備利潤性質的單一因素。但是,如果你能夠將注意力集中在細節上,總會有更多的事情需要發現。例如,許多人認爲高股本回報率是有利的商業經濟的標誌,而另一些人則喜歡 「關注資金」,尋找內部人士正在買入的股票。雖然可能需要你進行一些研究,但你可能會發現這份免費收集的擁有高股本回報率的公司,或者這份擁有大量內幕持股的股票清單很有用。
Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team (at) simplywallst.com.
This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.
對這篇文章有反饋嗎?對內容感到擔憂嗎?請直接聯繫我們。或者,也可以發送電子郵件至編輯團隊 (at) simplywallst.com。
Simply Wall St的這篇文章本質上是籠統的。我們僅使用公正的方法根據歷史數據和分析師的預測提供評論,我們的文章無意作爲財務建議。它不構成買入或賣出任何股票的建議,也沒有考慮到您的目標或財務狀況。我們的目標是爲您提供由基本數據驅動的長期重點分析。請注意,我們的分析可能不考慮最新的價格敏感型公司公告或定性材料。簡而言之,華爾街沒有持有任何上述股票的頭寸。